About ECRON AcuNova   Vision and Quality policy   Letter from Leaders      Letter from Vice Chairman      Letter from President   The Team   Fact sheet     LETTER FROM THE PRESIDENT     Having been in the industry for several decades, we have seen the progress of the industry and been a part of its evolution. The driver behind exponential growth of the European market is the increasing attractiveness of Eastern Europe to drug developers in both the US and Western Europe. A number of multi-centre clinical trials being carried out in the CEE region are growing on average at an annual rate of 30 per cent.   Some areas significantly impacting the European CRO industry today include globalization, the EU Clinical Trials Directive and EDC (electronic data capture). The EU Directive continues to create a challenge for trials in Europe and has increased the regulatory business for some of the big CRO's, adding another service for CRO's to provide to clients. In addition, EDC is making headway as companies look to improve the clinical trial process.   Partnerships with specialized CRO's in different regions always prove advantageous as they operate globally and have first hand experience of dealing with regional issues. As CRO's work internationally across different therapeutic areas and on different types of products they can often gain ideas on new approaches to important issues such as patient recruitment.   As these developments make way, we continue to look for opportunities to expand the industry and tap new markets. Our combined relationship with AcuNova has enabled us in tapping lucrative opportunities that prevail in countries like India. ECRON AcuNova combines experts in the clinical research space with the joint strength of two regional expert CRO's, from experienced geographies. The new entity will continue to be lead by our 20 years experience in addition to AcuNova being a reputed university CRO.   We believe this synergy will have a positive impact on the clinical research space and on the clients of both the company's. We are able to strengthen our expertise in clinical trials and data management from our Indian counterparts with faster patient enrolment in clinical trials, timely database lock, high quality early phase development as well as unique features like access to the Central Lab for Clinical Trial Testing. These services bring speed to projects, are of high quality and improve our competitiveness in Europe.   We look forward to our being your partner of choice and bringing value to the services we offer.   Dr K D Wiedey President ECRON AcuNova GmbH   < back

Privacy Policy     Disclaimer